Elopiprazole
![]()  | |
![]()  | |
| Clinical data | |
|---|---|
| Routes of administration  | Oral | 
| ATC code | 
  | 
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H22FN3O | 
| Molar mass | 375.447 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
Elopiprazole is an antipsychotic drug of the phenylpiperazine class which was never marketed.[1]
See also
- Phenylpiperazine
 
References
- ↑ van Wijngaarden I, Kruse CG, van Hes R, van der Heyden JA, Tulp MT (November 1987). "2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1". Journal of Medicinal Chemistry. 30 (11): 2099–104. doi:10.1021/jm00394a028. PMID 2889830.
 
| Typical | 
 
  | 
|---|---|
| Disputed | |
| Atypical | 
 
 
  | 
| Others | 
  | 
  | |
Serotonin receptor modulators  | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT1 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT2 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 | 
  | ||||||||||||||||||||||||||||||||||||||
  | |||||||||||||||||||||||||||||||||||||||
| Simple piperazines (no additional rings)  | 
  | 
|---|---|
| Phenylpiperazines | 
  | 
| Benzylpiperazines | |
| Diphenylalkylpiperazines (benzhydrylalkylpiperazines)  | 
  | 
| Pyrimidinylpiperazines | 
  | 
| Pyridinylpiperazines | 
  | 
| Benzo(iso)thiazolylpiperazines | |
| Tricyclics (piperazine attached via side chain)  | 
  | 
| Others/Uncategorized | 
  | 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

